Riskpilot← Back to searchSign inGet full accessSKIPPERGATA APOTEK AS
ASActiveOrg 824519722Skippergata 4, 3921 PorsgrunnRetail sale of pharmaceutical products · NACE 4773Est. 20200 employees
Revenue 2022
NOK 12,2M
+21% vs 2021
EBITDA margin
1.0%
+241% vs 2021
Equity ratio
-24.3%
Financial strength
Net profit 2022
NOK -259K
+44% vs 2021
| Revenue | NOK 12,2M | +21% |
| EBITDA | NOK 127K | +241% |
| Net profit | NOK -259K | +44% |
| Total assets | NOK 3,5M | +9% |
| Equity | NOK -840K | -45% |
| Employees | 0 | — |
Legal name
SKIPPERGATA APOTEK AS
Org number
824519722
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
30. januar 2020
Share capital
NOK 500 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Å eie og drive apotek og alt hva hermed står i forbindelse.
Address
Skippergata 4, 3921 Porsgrunn
Phone
+4735550500
Email
post@vitusapotek.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 |
|---|---|---|---|
| Revenue | 4 747 | 10 071 | 12 150 |
| Staff expenses | −1 520 | −2 639 | −2 955 |
| EBITDA | −348 | −91 | 127 |
| Depreciation & amort. | −188 | −283 | −283 |
| EBIT | −536 | −374 | −156 |
| Net financials | −86 | −90 | −103 |
| Profit before tax | −622 | −464 | −259 |
| Tax | −0 | −0 | −0 |
| Net profit | −622 | −464 | −259 |
| Item | 2020 | 2021 | 2022 |
|---|---|---|---|
| Total assets | 3 135 | 3 182 | 3 463 |
| Equity | −117 | −581 | −840 |
| Long-term debt | 2 117 | 1 641 | 1 149 |
| Short-term debt | 1 136 | 2 123 | 3 154 |
| Total debt | 3 253 | 3 763 | 4 303 |
EBITDA margin
1.0%
This company
15.8%
Market median
-94% vs market
20202022
Equity ratio
-24.3%
This company
38.2%
Market median
-164% vs market
20202022
Return on equity
-25892100.0%
This company
18.4%
Market median
-140718035% vs market
20202022
Net profit margin
-2.1%
This company
8.1%
Market median
-126% vs market
20202022
Asset turnover
3.51×
This company
1.12×
Market median
+213% vs market
20202022
Debt / equity
5.12×
This company
0.62×
Market median
-726% vs market
20202022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NA Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2023 | — | — | |
| Chairman | 2020 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Norsk Medisinaldepot As | Company | 100.0% | 100.0% | 2023 |
Apotekservice As | Company | 20.0% | 20.0% | 2022 |
Fraunar As | Company | 20.0% | 20.0% | 2022 |
Tr-H As | Company | 20.0% | 20.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Mckesson Norway Holding As
SKIPPERGATA APOTEK AS Board members of SKIPPERGATA APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nora Albakaa | Chief Executive Officer | 0 companies |
| Vegard Hoff | Board of Directors | 0 companies |
| Morten Frogner | Chairman | 0 companies |
| Michael Roland Ecker | Chairman | 0 companies |
| Jan Arne Frogner | Board of Directors | 0 companies |
| Einar Mathias Teigen Rasch-Halvorsen | Board of Directors | 0 companies |
| Anders Brekke | Board of Directors | 0 companies |